MedPath

thrombocytosis as a prognostic marker for head and neck cancer: a meta-analysis

Not Applicable
Conditions
head and neck squamous cell carcinoma
Registration Number
JPRN-UMIN000027656
Lead Sponsor
Osaka General Medical Center
Brief Summary

Elevated platelt count and platelet-to-lymphocyte ratio were associated with prognosis of patients with head and neck squamous cell carcinoma.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
2327
Inclusion Criteria

Not provided

Exclusion Criteria

(1) nonhuman studies and those in languages other than English, (2) studies focusing on thyroid cancer or nasopharyngeal cancer, (3) studies focusing on salivary gland cancer or nasal and paranasal cancer where SCC and non-SCC were analyzed together.

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
overall survival
Secondary Outcome Measures
NameTimeMethod
disease-specific survival
© Copyright 2025. All Rights Reserved by MedPath